AIFM2 and lung carcinoma: Moreover, FSP1 expression is highly correlated with ferroptosis-inducing agents (FINs, such as RSL3, ML162, ML210 and erastin) across a wide range of cancer cell lines, and potentially predicts ferroptosis sensitivity in lung cancer cells [12].